Swiss Chems🇺🇸

Swiss Chems receives the lowest editorial rating of any vendor in the KnowYourPeptide directory. The quality data on record for Swiss Chems is severely and comprehensively concerning, combining multiple catastrophic independent testing failures with a COA documentation program that provides no meaningful quality assurance for research use. This review explains the evidence in careful detail and why our recommendation is an unambiguous and unqualified directive to avoid this vendor entirely for any peptide research application. The Finnrick independent quality testing program data for Swiss Chems is among the most alarming in our entire vendor database. Finnrick purchases products anonymously from vendors at retail without their knowledge and subjects them to rigorous analytical testing including HPLC chromatography and biological activity assessment, producing results with no commercial bias toward any vendor outcome. Swiss Chems has ten Finnrick tested samples across three different compounds, and the results across all three compounds are deeply concerning. For CJC-1295, Swiss Chems received an E BAD rating with an average Finnrick score of 0.9 out of 10. An average score of 0.9 out of 10 on the Finnrick scale means that across multiple independently tested samples of Swiss Chems CJC-1295, the compound is essentially non-functional. This is not a marginal quality shortfall. This represents a product where the labeled compound is largely absent or completely degraded. Multiple community researchers have independently confirmed this: one researcher who submitted Swiss Chems CJC-1295 for HPLC analysis found essentially no detectable CJC-1295 after reconstitution. The compound appears to be absent, inactive, or entirely degraded. No research protocol can produce valid data using a compound that is not present in the vial at detectable concentrations. For Ipamorelin, Swiss Chems received a D POOR rating with a Finnrick score of 4.5 out of 10. A D POOR rating means the compound is present but at concentrations or activity levels that are meaningfully below label claims. Ipamorelin is a growth hormone secretagogue where dosing accuracy directly affects the amplitude of GH pulse stimulation, which is the primary research variable in any study using this compound. Using a D POOR Ipamorelin while believing it to be at label concentration means every dosing calculation, every observed GH response, and every research conclusion built on that data is based on incorrect foundational assumptions. The research data generated is invalid, not just suboptimal. Only BPC-157 from Swiss Chems achieved a C OKAY rating on Finnrick, meaning it barely reached the passing threshold. This is the sole compound in their Finnrick dataset that could be described as adequate rather than poor or essentially inactive. Two of three independently tested compound categories failed. The one that passed did so at the minimum acceptable level. This represents the worst aggregate quality profile across all vendors in our database, not a marginal concern but a systematic quality failure across the product range that has been independently tested. The COA documentation at Swiss Chems does not provide independent third-party batch verification. There is no external accredited laboratory producing lot-specific certificates of analysis with independent accountability for the results. The documentation available to customers is generated through processes that lack external verification and the accountability that comes with it. When the Finnrick data shows an average of 0.9 out of 10 on CJC-1295, indicating essentially no active compound, a documentation program with no external verification has no mechanism to detect, flag, or prevent this from happening. The documentation failure and the product failure are directly connected. Community reviews for Swiss Chems are consistently and strongly negative. Researchers who have taken the time to independently test Swiss Chems products and share their results describe HPLC findings fully consistent with the Finnrick data. One community reviewer confirmed no detectable CJC-1295 in their sample, aligning exactly with the Finnrick 0.9 out of 10 score. The community data is not just directionally consistent with the independent testing data. It is quantitatively consistent, which is the highest level of corroboration available from multiple independent sources. The research consequences of using Swiss Chems products are severe and extend beyond wasted budget. A researcher using Swiss Chems CJC-1295 at a dose designed for active compound is administering a product with no detectable active peptide. No GH secretagogue effect occurs. If this research is compared to a control group or used to draw conclusions about CJC-1295 pharmacology, the conclusions are wrong by definition. Any publication, dataset, or protocol built on Swiss Chems CJC-1295 or Ipamorelin data should be treated as potentially unreliable and requiring repetition with verified compounds before any confidence can be placed in the outcomes. The appropriate vendor response to Finnrick E BAD ratings is to recall affected lots, investigate the failure, commission independent retesting of new production, and publish the results transparently. No such documented response has appeared in the public record for Swiss Chems. The absence of any visible quality remediation response to published E BAD data is itself a meaningful signal about how this vendor prioritizes quality accountability. Our recommendation: Do not purchase peptides from Swiss Chems under any circumstances for research use. The combination of essentially inactive CJC-1295 confirmed by Finnrick and multiple independent community tests, D POOR Ipamorelin, the absence of credible independent COA documentation, consistently negative community reviews, and no documented quality remediation response constitutes the highest-risk vendor profile in our database. No pricing advantage, convenience factor, or compound availability consideration justifies the research quality risk. Redirect all sourcing to vendors with independent third-party batch testing programs, with Koi Peptides, Core Peptides, or Sports Technology Labs as primary alternatives. Grade D. Do not use.

— KnowYourPeptide Research Team